Log in
Enquire now
Anagenesis Biotechnologies

Anagenesis Biotechnologies

Anagenesis Biotechnologies is a biotechnology company developing pre-clinical stem cell therapies for treating genetic and age-related muscle degenerative diseases.

OverviewStructured DataIssuesContributors

Anagenesis Biotechnologies is a preclinical-stage biotechnology company focused on the development of therapeutics that slow muscular degenerative disorders from genetic- or age-related diseases, and on medical needs in the field of muscle and metabolic diseases.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Anagenesis Biotechnologies secures a new investment from Cap Innov'Est | French Tech Hub

Robin Flamant

https://frenchtechhub.com/2015/06/congratulations-to-anagenesis-biotechnologies-for-securing-a-new-investment-from-cap-innovest/

Web

CRISPR Therapeutics and Anagenesis Biotechnologies Announce Strategic In-Licensing and Collaboration Agreement to Develop CRISPR/Cas9-based Cell Therapies for Muscle Diseases

Business Wire

https://www.businesswire.com/news/home/20160608005400/en/CRISPR-Therapeutics-Anagenesis-Biotechnologies-Announce-Strategic-In-Licensing

Web

CRISPR Thx in yet another Collaboration, this time for Muscle Dystrophy

Denise Neves Gameiro

https://labiotech.eu/medical/crispr-in-yet-another-collaboration-this-time-for-muscle-dystrophy/

Web

References

Find more companies like Anagenesis Biotechnologies

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.